A detailed history of Iag Wealth Partners, LLC transactions in Novavax Inc stock. As of the latest transaction made, Iag Wealth Partners, LLC holds 61 shares of NVAX stock, worth $556. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 61 -0.0%
Holding current value
$556
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$36.28 - $75.29 $1,922 - $3,990
-53 Reduced 46.49%
61 $3,000
Q1 2021

Apr 29, 2021

BUY
$112.98 - $319.93 $12,879 - $36,472
114 New
114 $21,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $713M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Iag Wealth Partners, LLC Portfolio

Follow Iag Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iag Wealth Partners, LLC with notifications on news.